$莱斯康制药(LXRX)$ 8-K - Current report Filed: 2018-09-04 AccNo: 0001062822-18-000030 Size: 462 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantItem 9.01: Financial 网页链接